REVA MEDICAL, INC RVA - Company Profile and Status at InvestoGain Australia

SEARCH BY NAME

BROWSE

Browse Australian listed companies0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Browse current Australian managed funds0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Browse Australian delisted companies/archived fundsor use SEARCH

SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

REVA MEDICAL, INC (RVA)

Listed on ASX ( $0.580 +0.020 +3.57%)

Former (or subsequent) names

Shareholder links

Our website ranking of RVA:
(4 out of 5)

COMPANY WEBSITE:

RVA website

RVA email

RVA investorRelations

RVA announcements

REGISTRY:
Computershare, Level 3, 60 Carrington Street, Sydney NSW 2000
Tel : +61 2 8234 5000
Fax : +61 2 8235 8150
RegistryWebsite RegistryEmail

Company details

Address: C/- Inteq Limited, Level 6, 175 Macquarie Street, SYDNEY, NSW, AUSTRALIA, 2000
Tel: (858) 966-3000 Fax: (858) 966-3099

Date first listed: 23/12/2010
Company Secretary: Katrina Thompson
Sector: Health Care Equipment & Services Industry Group:
Activities: Development of medical devices, specifically bioresorbable stent products

News & Events

Expand this box

listed entity carried for record purposes only

23/12/2010

ASX Announcements (courtesy of ASX)

Date	Price sens.	Headline	Pages	PDF	PDF
Date	Price sens.	Headline	Pages	PDF	Edited text*
16/05/2013		AGM Dial-In Details	1	PDF	-
14/05/2013		Appointment of Managing Director International	2	PDF	-
09/05/2013		Quarterly Report on Form 10-Q	26	PDF	-
30/04/2013		Appendix 4C - quarterly	7	PDF	-
19/04/2013		Proxy Statement for 2013 AGM	59	PDF	-
28/03/2013		ReZolve2 Clinical Trial Initiation	2	PDF	-
01/03/2013		Form S-8 Filed with SEC	10	PDF	-
28/02/2013		Notice of Briefing Call & Cowen HC Conference Presentation	2	PDF	-
28/02/2013		Preliminary Final Report	109	PDF	-
21/02/2013		Presentation at CRT Conference	1	PDF	-

Your comments

Please read our Terms before viewing comments.

Company Updates

Post your comments here

Please read our Terms before posting comments.

Directors' share transactions (last 5)

Purchases Sales

DATE	DIRECTOR	NATURE	NUMBER	PRICE	AMOUNT
13/09/2012	Robert Thomas	On market CDIs	30,000	$0.515	$15,450
28/08/2012	Robert Thomas	On market CDIs	70,000	$0.543	$38,000
13/06/2012	Robert Thomas	On market CDIs	50,000	$0.650	$32,500
04/06/2012	Robert Thomas	On market CDIs	100,000	$0.625	$62,500
30/05/2012	Robert Thomas	On market CDIs	31,500	$0.663	$20,875

Click here for the last 20 transactions all companies

Directors & Executives (current)

NAME	TITLE	DATE OF APPT
Robert Stockman	Chairman, CEO
Katrina Thompson	CFO
Robert Thomas	Director
James Schiro	Director
Gordon Nye	Director
Anne Keating	Director
Brian Dovey	Director